Ozagrel

DB12017InvestigationalSmall molecule

Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

Chemical structure of Ozagrel
Mechanism
Curator reviewed
Formula / weight
C13H12N2O2 · 228.251 g/mol (avg)
Code names
KCT-0809

Resolves to

Compound
UNIIL256JB984DCAS82571-53-7ChEMBLCHEMBL11662ChEBI134938PubChem5282440
Structure
InChIKeySHZKQBHERIJWAO-AATRIKPKSA-NSMILESOC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1
Targets
P24557TBXAS1Q16539MAPK14

What you can answer from here — as of September 19, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ozagrel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In